Rubicon Organics Inc. carries a market capitalization of 21.21M, placing it among publicly traded companies globally. Its enterprise value stands at 44.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 21.21M |
| Enterprise Value | 44.19M |
Rubicon Organics Inc. currently has 67.58M shares outstanding.
| Shares Outstanding | 67.58M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Rubicon Organics Inc. trades at a trailing price-to-earnings ratio of 115.11. The price-to-sales ratio is 0.56, and the price-to-book ratio stands at 2.08.
| PE Ratio | 115.11 |
| PS Ratio | 0.56 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | 3.47 |
| P/OCF Ratio | 1,997.42 |
On an enterprise value basis, Rubicon Organics Inc. trades at an EV/EBITDA multiple of 13.98 and an EV/FCF ratio of 4.12. The EV/Sales ratio of 0.73 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 38.60 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.73 |
| EV / EBITDA | 13.98 |
| EV / EBIT | 38.60 |
| EV / FCF | 4.12 |
Rubicon Organics Inc. maintains a current ratio of 2.54, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.26, indicating elevated leverage, while an interest coverage ratio of 4.23 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.54 |
| Quick Ratio | 0.65 |
| Debt / Equity | 32.26 |
| Debt / EBITDA | 4.25 |
| Interest Coverage | 4.23 |
| Return on Equity (ROE) | -9.10 |
| Return on Assets (ROA) | -2.27 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 19.58 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.24 |
Rubicon Organics Inc.'s stock has declined approximately -1.22607% over the past 52 weeks. The 50-day moving average sits at 0.36, while the 200-day moving average is 0.37.
| Beta (5Y) | N/A |
| 52-Week Price Change | -1.22607% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 0.37 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Rubicon Organics Inc. generated 60.76M in revenue and converted that into -1.38M in net income, yielding earnings per share of -0.02. EBITDA reached 3.16M, while operating income came in at -593,208.00.
| Revenue | 60.76M |
| Gross Profit | 21.38M |
| Operating Income | -593,208.00 |
| Pretax Income | -1.38M |
| Net Income | -1.38M |
| EBITDA | 3.16M |
| EBIT | -593,208.00 |
| Earnings Per Share (EPS) | -0.02 |
Rubicon Organics Inc. holds 3.20M in cash and equivalents against 13.43M in total debt, resulting in a net debt position of 8.64M. Total book value stands at 16.31M, with working capital of 20.19M providing operational flexibility.
| Cash & Cash Equivalents | 3.20M |
| Total Debt | 13.43M |
| Net Debt | 8.64M |
| Equity (Book Value) | 16.31M |
| Book Value Per Share | 0.24 |
| Working Capital | 20.19M |
Rubicon Organics Inc. produced 17,000.00 in operating cash flow over the past twelve months. After subtracting -9.95M in capital expenditures, free cash flow totaled -9.94M - equivalent to -0.15 per share.
| Operating Cash Flow | 17,000.00 |
| Capital Expenditures | -9.95M |
| Free Cash Flow | -9.94M |
| FCF Per Share | -0.15 |
Rubicon Organics Inc. operates with a gross margin of 35.19, reflecting its pricing power and cost economics. The operating margin of -0.98 and net profit margin of -2.27 provide insight into operational efficiency.
| Gross Margin | 35.19 |
| Operating Margin | -0.98 |
| Pretax Margin | -2.27 |
| Profit Margin | -2.27 |
| EBITDA Margin | 5.20 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -16.03 |
| FCF Yield | 28.82 |
Rubicon Organics Inc. posts an Altman Z-Score of 0.03, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.03 |